Mangalam Drugs and Organics moves up on getting CEP for Hydroxychloroquine Sulphate

20 May 2020 Evaluate
Mangalam Drugs & Organics is currently trading at Rs. 72.00, up by 0.75 points or 1.05% from its previous closing of Rs. 71.25 on the BSE.

The scrip opened at Rs. 67.70 and has touched a high and low of Rs. 74.80 and Rs. 67.70 respectively. So far 66243 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 10 has touched a 52 week high of Rs. 101.50 on 12-May-2020 and a 52 week low of Rs. 20.40 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 83.00 and Rs. 67.70 respectively. The current market cap of the company is Rs. 113.96 crore.

The promoters holding in the company stood at 50.53%, while Institutions and Non-Institutions held 0.08% and 49.39% respectively.

Mangalam Drugs and Organics has received Certificate of Suitability (CEP) for API - Hydroxychloroquine Sulphate (HCQS) from European Directorate for the Quality of Medicines & Healthcare (EDOM).

Mangalam Drugs and Organics manufactures chemicals such as API perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates at VAPI-Gujarat State. It has a multi-product manufacturing facility and a in-house Research and Development (R&D) Base.

Mangalam Drugs&Org. Share Price

106.90 2.10 (2.00%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.